Marinus Pharmaceuticals' Series B Round

Marinus Pharmaceuticals raised a round of funding on April 24, 2009.

Marinus Pharmaceuticals is a privately held specialty pharmaceutical company dedicated to the reformulation, development, and commercialization of ganaxolone to treat serious neurological and psychiat…

Articles about Marinus Pharmaceuticals' Series B Round: